 |
|
|
|
 |
|
|
| Article 1 to 8 out of 8 concerning DIREVO Biotech AG
|
-
Direvo and Danisco/Genencor sign second cooperation agreement
(07/03/2008)
DIREVO Biotech AG and Genencor Division of Danisco A/S announced the signing of their second collaboration agreement.Under the terms of the agreement, Danisco will obtain worldwide exclusive rights to commercialize the product or products developed ...
-
DIREVO Receives Broad European Patent Protection for its Protease Optimization Platform
(06/25/2008)
DIREVO Biotech AG announced receipt of notice from the European Patent Office that the post-granting opposition period had ended without a filed opposition against Patent Grant No. EP 150411. This patent, entitled, "Process for Generating ...
-
DIREVO announces validation of bestMab
(05/08/2008)
New approach for the optimization of therapeutic antibodies generates optiMIRA, an enhanced version of Adalimumab (Humira)
DIREVO Biotech AG announced that it has validated its "bestMab(TM)" platform through the generation of an optimized version of the anti-inflammatory antibody, Adalimumab (Humira®), with unprecedentedly strong binding properties. optiMIRA(TM) shows ...
-
DIREVO to collaborate with MedImmune on therapeutic protease for the treatment of CNS diseases
(01/25/2008)
DIREVO Biotech AG announced the signing of a research and license agreement with MedImmune, the global biologics unit of AstraZeneca plc, to develop a therapeutic protease for the treatment of CNS diseases. Under the terms of the agreement, Direvo ...
-
DIREVO and Pfizer collaborate on therapeutic proteases
(11/13/2007)
DIREVO Biotech AG announced the signing of a collaboration agreement with Pfizer, Inc., New York, to develop therapeutic proteases for different targets as potential treatments for various diseases. Direvo will apply its protein-engineering ...
-
Direvo Acquires AC Biotec
(11/07/2007)
DIREVO Biotech AG announced that it has acquired AC Biotec GmbH in an all cash transaction. AC Biotec will continue to operate as an independent, fully-owned subsidiary of Direvo Biotech with Dr. Simon Curvers continuing as Managing Director. This ...
-
Direvo and Danisco Collaboration Yields New Industrial Enzyme
(10/31/2007)
DIREVO Biotech AG announced that an industrial enzyme protein engineering project in collaboration with Danisco A/S, has yielded a significantly improved phytase enzyme. The project exploited Direvo's high throughput, robotic screening and directed ...
-
Direvo Biotech achieves major breakthrough by validating therapeutic, anti-inflammatory NBE® Protease in vivo
(10/24/2005)
Direvo Biotech AG announced the successful in vivo validation of its NBE® Protease technology for the development of tailor-made proteases. The NBE® technology is the first approach to enable the engineering of proteases that specifically activate ...
Additional information
DIREVO Biotech AG
Köln, Germany
Company
|
|
|
|
|
|
Top
